Cellectis S.A.
CLLSNasdaqHealthcare · Biological Products, (No Diagnostic Substances) · I0 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Bpifrance Participations SaActivist (13D)Dec 12, 2025
- Astrazeneca PlcActivist (13D)Jan 24, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 337,444 | 15.3 | -7.3% |
| Apr 30, 2026 | 364,178 | 15.2 | -5.0% |
| Apr 15, 2026 | 383,347 | 7.8 | +6.9% |
| Mar 31, 2026 | 358,609 | 9.4 | +2.2% |
| Mar 13, 2026 | 350,861 | 5.0 | -9.7% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KMay 21, 2026
- 6-KFORM 6-KMay 20, 2026
- 6-KFORM 6-KMay 12, 2026
- 6-KFORM 6-KMay 11, 2026
- 6-KMay 11, 2026
- 6-KFORM 6-KMay 4, 2026
- 6-KFORM 6-KApr 27, 2026
- 6-KFORM 6-KApr 13, 2026
- 20-FMar 20, 2026
- 6-KFORM 6-KMar 20, 2026
- 6-KFORM 6-KMar 12, 2026
- 6-KFORM 6-KJan 8, 2026
- 6-KFORM 6-KDec 15, 2025
- SCHEDULE 13D/ADec 12, 2025
- 6-KFORM 6-KDec 8, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.